Insidertrades

Veracyte

VCYT

Insider trades and stock quote 2024-2026

All insider trades at Veracyte

Subscribe RSS
Date Type Insider Position Ø-Price Volume
9/4/2026 Sell Febbo, Phillip G. Chief Scientific & Med Officer $43.3 $564,410
9/4/2026 Sell Chambers, Rebecca Chief Financial Officer $43.3 $157,394
9/4/2026 Sell Mcguire, Annie EVP, General Counsel $43.2 $140,212
9/1/2026 Sell Bhanji, Muna Director $43.0 $80,096
6/18/2026 Sell Eastham, Karin Director $53.2 $197,234
6/4/2026 Sell Stapley, Marc Chief Executive Officer $50.1 $6,919,585
6/4/2026 Sell Chambers, Rebecca Chief Financial Officer $49.7 $177,083
6/4/2026 Sell Mcguire, Annie EVP, General Counsel $49.7 $158,036
6/4/2026 Sell Leite, John Global Chief Commercial Off $50.1 $699,732
5/22/2026 Sell Wygant, Jonathan VP, Chief Accounting Officer $45.4 $1,089,624
5/20/2026 Sell Epstein, Robert S. Director $44.0 $440,129
5/6/2026 Sell Mcguire, Annie SVP, General Counsel $39.0 $398,211
3/4/2026 Sell Stapley, Marc Chief Executive Officer $35.9 $1,637,594
3/4/2026 Sell Chambers, Rebecca Chief Financial Officer $35.9 $662,869
3/4/2026 Sell Mcguire, Annie SVP, General Counsel $35.8 $236,725
3/4/2026 Sell Leite, John Chief Commercial Officer-CLIA $35.2 $185,083
3/2/2026 Sell Febbo, Phillip G. Chief Scientific & Med Officer $36.2 $485,429
12/16/2025 Sell Mcguire, Annie SVP, General Counsel $43.4 $463,204
12/5/2025 Sell Eastham, Karin Director $45.6 $908,923
12/4/2025 Sell Stapley, Marc Chief Executive Officer $47.1 $361,075
12/4/2025 Sell Chambers, Rebecca Chief Financial Officer $46.9 $621,955
12/4/2025 Sell Mcguire, Annie SVP, General Counsel $47.3 $67,261
12/4/2025 Sell Leite, John Chief Commercial Officer-CLIA $47.5 $60,718
11/25/2025 Sell Jones, Evan Director $50.2 $55,576
11/25/2025 Sell Leite, John Chief Commercial Officer-CLIA $50.0 $140,400
11/20/2025 Sell Holstein, Jens Director $42.2 $423,563
11/10/2025 Sell Wygant, Jonathan VP, Chief Accounting Officer $42.3 $215,978
11/7/2025 Sell Wygant, Jonathan VP, Chief Accounting Officer $40.2 $233,929
11/5/2025 Sell Jones, Evan Director $44.3 $1,946,287
11/5/2025 Sell Eastham, Karin Director $40.0 $387,191
11/5/2025 Sell Chambers, Rebecca Chief Financial Officer $41.0 $287,000
11/5/2025 Sell Mcguire, Annie SVP, General Counsel $40.0 $258,640
10/6/2025 Sell Febbo, Phillip G. Chief Scientific & Med Officer $36.0 $300,709
10/1/2025 Sell Epstein, Robert S. Director $35.1 $753,204
10/1/2025 Sell Mcguire, Annie SVP, General Counsel $35.0 $75,608
10/1/2025 Sell Leite, John Chief Commercial Officer-CLIA $35.0 $88,865
9/19/2025 Sell Mcguire, Annie SVP, General Counsel $33.7 $76,920
9/4/2025 Sell Stapley, Marc Chief Executive Officer $30.4 $233,133
6/13/2025 Sell Bhanji, Muna Director $26.7 $122,367
6/13/2025 Sell Eastham, Karin Director $26.7 $122,388
6/4/2025 Sell Leite, John Chief Commercial Officer-CLIA $27.2 $76,410
3/7/2025 Sell Leite, John Chief Commercial Officer-CLIA $31.5 $234,630
3/4/2025 Sell Mcguire, Annie SVP, General Counsel $33.7 $38,476
3/4/2025 Sell Stapley, Marc Chief Executive Officer $33.7 $1,756,856
3/4/2025 Sell Febbo, Phillip G. Chief Scientific & Med Officer $33.4 $268,013
2/27/2025 Sell Leite, John Chief Commercial Officer-CLIA $33.8 $194,445
2/3/2025 Sell Chambers, Rebecca Chief Financial Officer $43.8 $23,109
1/2/2025 Sell Eastham, Karin Director $40.3 $403,006
12/13/2024 Sell Stapley, Marc Chief Executive Officer $43.8 $242,737
12/4/2024 Sell Mcguire, Annie SVP, General Counsel $44.0 $823,179
12/4/2024 Sell Febbo, Phillip G. Chief Scientific & Med Officer $44.1 $173,447
12/3/2024 Sell Wygant, Jonathan VP, Chief Accounting Officer $43.4 $41,452
12/3/2024 Sell Chambers, Rebecca Chief Financial Officer $43.2 $302,622
12/3/2024 Sell Leite, John Chief Commercial Officer-CLIA $43.2 $45,408
11/27/2024 Sell Wygant, Jonathan VP, Chief Accounting Officer $42.9 $215,834
11/19/2024 Sell Eastham, Karin Director $37.8 $564,769
11/12/2024 Sell Epstein, Robert S. Director $38.3 $574,830
11/12/2024 Sell Chambers, Rebecca Chief Financial Officer $38.3 $585,663
9/19/2024 Sell Jones, Evan Director $35.2 $182,263
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)